SOX2 and cancer: Further research has highlighted the key roles of TFs, SOX2, and SOX9, in defining the identity of latency-competent cancer (LCC) cells, with differential expressions impacting the epigenetic landscape and transcriptional activity across lung and breast cancer BrM models [102].